Homepage

Option Care Health, Inc.

OPCH NASDAQ Categories PDF
Healthcare · Medical - Care Facilities · United States · Updated May 11, 1:56pm
$19.95
Price
$3.1B
Market Cap
8,000
Employees
0.68
Beta
Luke Whitworth
CEO
Business Description

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; infusion therapies for bleeding disorders; therapies that women need to survive and thrive through high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.

Business History
Price Overview
Last updated: May 11, 2026 1:56pm (just now)
$19.95
-0.56 (-2.75%)
Day Range
$19.93 – $20.98
52-Week Range
$18.01 – $36.80
50-Day MA
$27.66
200-Day MA
$29.67
Volume
2,392,814.73
Analyst Price Targets
Low $26.00
Consensus $32.38
High $39.00
(21 analysts)
Share Structure
Outstanding 157,027,504.00
Float 146,883,527.00
Free Float 93.5%
High free float — 93.5% of shares trade freely, ~6.5% held by insiders/institutions
Very liquid — most shares trade freely. Low insider ownership can mean less management alignment, but makes large position sizing straightforward.
Price History (1 Year)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
Period Revenue Net Income Net Margin YoY/QoQ
Key Metrics
API Direct from provider CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
API
Stock Price / EPS (Diluted)
15.15
Stock Price: $19.95
EPS (Diluted): 1.28
P/B Ratio (Price vs net asset value)
API
Stock Price / Book Value Per Share
3.89
Stock Price: $19.95
Total Equity: $1.33B
Shares: 163,365,000
EV/EBITDA (Total value vs operating profit)
API
Enterprise Value / EBITDA
7.28
Market Cap: $3.13B
Total Debt: $0.00
Cash: $232.62M
EBITDA: $408.60M
Enterprise Value (Takeover price (cap + debt - cash))
API
Market Cap + Total Debt - Cash
$4.9B
Market Cap: $3.13B
Total Debt: $0.00
Cash: $232.62M
Gross Margin (Revenue left after direct costs)
API
Gross Profit / Revenue
18.1%
Gross Profit: $1.02B
Revenue: $5.65B
Operating Margin (Revenue left after all operations)
API
Operating Income / Revenue
6.0%
Operating Income: $337.91M
Revenue: $5.65B
Net Margin (Revenue left as actual profit)
API
Net Income / Revenue
3.7%
Net Income: $207.59M
Revenue: $5.65B
ROE (Profit from shareholder equity)
API
Net Income / Total Equity
15.3%
Net Income: $207.59M
Total Equity: $1.33B
ROIC (Profit from all invested capital)
API
NOPAT / Invested Capital
9.3%
Operating Income: $337.91M
Tax Rate: 26.6%
Equity: $1.33B
Total Debt: $0.00
Cash: $232.62M
Zero debt — invested capital = equity minus cash (very efficient)
Current Ratio (Can it pay short-term bills)
API
Current Assets / Current Liabilities
1.53
Current Assets: $1.26B
Current Liabilities: $829.35M
Debt/Equity (Leverage — debt vs equity)
CALC
Total Debt / Total Equity
0.00
Short-Term Debt: $0.00
Long-Term Debt: $0.00
Total Debt: $0.00
Total Equity: $1.33B
Zero debt — this company carries no debt obligations. Strongest possible score.
Rev/Share (Top-line per share)
CALC
Revenue / Shares Outstanding
$34.58
Revenue: $5.65B
Shares: 163,365,000
Book Value/Share (Net assets per share)
CALC
(Total Assets - Total Liabilities) / Shares
$8.12
Total Equity: $1.33B
Shares: 163,365,000
FCF/Share (Real cash generated per share)
CALC
(Operating Cash Flow + CapEx) / Shares
$1.58
Operating CF: $258.45M
CapEx: $0.00
Shares: 163,365,000
Div Yield (Annual income from holding)
API
Last Annual Dividend / Stock Price
0.0%
Last Dividend: N/A
Stock Price: $19.95
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
—
Dividends Paid: N/A
Net Income: $207.59M
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares OPCH against LLM-researched typical ranges for its industry. One research call per industry, cached indefinitely — every stock in the same industry reuses the same baseline.
Deep Analysis

Pre-flight intelligence scans the company first, then routes to the right analytical methods.

0 Company Classification — What type of company is this?
1 Industry Landscape — Where is the industry headed?
2 Company Momentum — Where is this company trending?
3 Forward Projection — 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a DCF Valuation — Present value of future cash flows
4b Earnings Power Value — Floor value — worth with zero growth
4c Anchored PE — Industry PE adjusted for growth differential
4d Reverse DCF — What growth is the market pricing in?
4e Revenue-Based DCF — For growth/narrative companies (skip if mature earner)
4f Anchored P/S — Price-to-Sales peer comparison (skip if mature earner)
4g Scenario Analysis — Bull / Base / Bear (skip if mature earner)
4h Dividend Discount Model — For dividend/income stocks only
4i Book Value Analysis — For deep value / turnaround stocks only
4j Insider Activity — Are insiders buying or selling?
4f Cash Flow Quality — How trustworthy is the FCF?
4g Debt Maturity Risk — Can it handle its debt?
4h Macro Environment — Rates, market valuation, volatility
4i Sector Intelligence — How does this company compare within its sector?
4j Revenue Confidence — How reliable is the growth projection?
4k Sensitivity Analysis — How fragile is the fair value estimate?
4l Sector Demand Cycle — Is the sector in a boom, steady state, or contraction?
5 AI Investigation — Adaptive research engine (Claude)
5b Thesis Evaluation — What does the market believe? (narrative/platform stocks only)
6 Valuation Synthesis — Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Metric 2021 2022 2023 2024 2025
Revenue $3.4B $3.9B $4.3B $5.0B $5.6B
Cost of Revenue $2.7B $3.1B $3.3B $4.0B $4.6B
Gross Profit $779.6M $866.9M $981.2M $1.0B $1.0B
Operating Expenses $588.8M $626.7M $666.6M $691.2M $682.5M
Operating Income $190.8M $240.2M $314.6M $321.8M $337.9M
Net Income $139.9M $150.6M $267.1M $211.8M $207.6M
EBITDA $252.3M $325.0M $472.2M $396.1M $408.6M
EPS $0.78 $0.83 $1.49 $1.23 $1.28
EPS (Diluted) — — — — —
Balance Sheet (Annual)
Metric 2021 2022 2023 2024 2025
Cash & Equivalents $119.4M $294.2M $343.8M $412.6M $232.6M
Total Current Assets $710.3M $994.3M $1.1B $1.3B $1.3B
Total Assets $2.9B $3.2B $3.3B $3.4B $3.5B
Current Liabilities $459.7M $565.4M $618.3M $780.1M $829.3M
Long-Term Debt $1.1B $1.1B $1.1B $1.1B $0
Total Liabilities $1.7B $1.8B $1.9B $2.0B $2.1B
Total Equity $1.2B $1.4B $1.4B $1.4B $1.3B
Retained Earnings $39.9M $190.4M $457.5M $669.3M $0
Cash Flow (Annual)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow $208.6M $267.5M $371.3M $323.4M $258.4M
Capital Expenditure -$25.6M -$35.4M -$41.9M -$35.6M $0
Free Cash Flow $182.9M $232.2M $329.4M $287.8M $258.4M
Acquisitions (net) -$85.9M -$87.4M -$12.5M $0 -$117.2M
Debt Repayment — — — — —
Dividends Paid — — — — —
Stock Buybacks $-32,000 $0 -$250.3M -$252.7M -$310.0M
Net Change in Cash $20.2M $174.8M $49.7M $68.7M -$179.9M
Analyst Estimates (Annual)
Metric 2027 2028 2029 2030
Revenue $6.1B
$6.1B – $6.2B
 $6.7B
$6.7B – $6.7B
 $7.2B
$7.1B – $7.3B
 $7.7B
$7.6B – $7.8B
EBITDA $511.6M
$506.6M – $516.6M
 $555.9M
$555.9M – $555.9M
 $601.2M
$595.7M – $607.9M
 $642.5M
$636.6M – $649.6M
Net Income $338.0M
$326.4M – $349.5M
 $378.4M
$356.3M – $400.5M
 $406.8M
$401.9M – $412.6M
 $450.9M
$445.5M – $457.3M
EPS — — — —
Growth Trends (YoY %)
Metric 2022 2023 2024 2025
Revenue Growth +14.7% +9.1% +16.2% +13.0%
Gross Profit Growth +11.2% +13.2% +3.2% +0.7%
Operating Income Growth +25.9% +31.0% +2.3% +5.0%
Net Income Growth +7.6% +77.4% -20.7% -2.0%
EBITDA Growth +28.8% +45.3% -16.1% +3.1%
Insider Trading (Recent)
Date Insider Type Shares Price Value
2026-05-07 SULLIVAN TIMOTHY P P-Purchase 24,154.00 $20.69 $499,671
2026-05-04 KRAEMER HARRY M JANSEN JR P-Purchase 36,610.00 $21.41 $783,773
2026-05-04 Sethna Meenal P-Purchase 16,225.00 $20.16 $327,075
2026-05-04 RADEMACHER JOHN CHARLES P-Purchase 12,500.00 $21.18 $264,706
2026-04-22 Adewunmi Femi F-InKind 1,396.00 $28.38 $39,618
2026-02-27 Pate R Carter S-Sale 30,287.00 $32.05 $970,620
2026-02-27 Bavaro Michael S-Sale 6,000.00 $33.00 $198,000
2026-02-24 Whitworth Luke F-InKind 4,605.00 $33.82 $155,718
2026-02-24 Grashoff Christopher L. F-InKind 1,980.00 $33.82 $66,954
2026-02-24 Smyser Collin F-InKind 2,210.00 $33.82 $74,731
2026-02-24 Adewunmi Femi F-InKind 1,627.00 $33.82 $55,017
2026-02-24 RADEMACHER JOHN CHARLES F-InKind 11,050.00 $33.82 $373,656
2026-02-24 Bavaro Michael F-InKind 1,354.00 $33.82 $45,786
2026-02-24 Maggio Nicole F-InKind 975.00 $33.82 $32,970
2026-02-20 Bavaro Michael F-InKind 1,187.00 $35.69 $42,364
2026-02-22 Bavaro Michael F-InKind 12,212.00 $35.69 $435,846
2026-02-20 Grashoff Christopher L. F-InKind 1,948.00 $35.69 $69,524
2026-02-22 Grashoff Christopher L. F-InKind 538.00 $35.69 $19,201
2026-02-20 Maggio Nicole F-InKind 619.00 $35.69 $22,092
2026-02-22 Maggio Nicole F-InKind 372.00 $35.69 $13,277
Community AI Feedback
Sign in to Contribute
No community reviews yet for OPCH. Be the first — export the analysis to your AI and contribute back.
My Notes personal — only you see this
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.193 · 1946f027 · 2026-05-08 18:57:27